Junyan Lu
Impact in
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Sphingolipid Metabolism and Signaling
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 10
- Cancer-related gene regulation 6
- PI3K/AKT/mTOR signaling in cancer 5
- Glycosylation and Glycoproteins Research 4
- Sphingolipid Metabolism and Signaling 4
- Genetics 17
- Chronic Lymphocytic Leukemia Research 17
- Co-authors
- Cheng Luo (30 shared papers)Hualiang Jiang (17 shared papers)Xiangqian Kong (13 shared papers)Zhongjie Liang (9 shared papers)Sisheng Ouyang (5 shared papers)Liang Zhang (1 shared paper)Guoliang Xu (1 shared paper)Qing Dai (1 shared paper)
- Journals
- Blood (7 papers)PLoS ONE (4 papers)Leukemia (3 papers)Journal of Medicinal Chemistry (2 papers)Cell chemical biology (2 papers)
- Partner nations
- ChinaGermanySwitzerland
In The Last Decade
Junyan Lu
57 papers receiving 1.9k citations
Junyan Lu's Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 1.3k
- Genetics 138
- Computational Theory and Mathematics 197
- Molecular Medicine 50
- Oncology 251
Countries citing papers authored by Junyan Lu
This map shows the geographic impact of Junyan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Lu more than expected).
Fields of papers citing papers by Junyan Lu
This network shows the impact of papers produced by Junyan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Lu. The network helps show where Junyan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 265 | |
| 2 | 2012 | 264 | |
| 3 | Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer Hit paper breakdown → | 2020 | 252 |
| 4 | 2014 | 175 | |
| 5 | 2014 | 92 | |
| 6 | 2015 | 56 | |
| 7 | 2013 | 50 | |
| 8 | 2020 | 48 | |
| 9 | 2011 | 40 | |
| 10 | 2017 | 39 | |
| 11 | 2014 | 39 | |
| 12 | 2013 | 39 | |
| 13 | 2017 | 38 | |
| 14 | 2015 | 38 | |
| 15 | 2012 | 32 | |
| 16 | 2016 | 31 | |
| 17 | 2014 | 31 | |
| 18 | 2014 | 26 | |
| 19 | 2015 | 25 | |
| 20 | 2021 | 24 |
About Junyan Lu
Junyan Lu is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Pathology and Forensic Medicine, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Genetics (138 citations), Computational Theory and Mathematics (197 citations), Molecular Medicine (50 citations) and Oncology (251 citations). Junyan Lu has collaborated with scholars based in China, Germany and Switzerland. Frequent co-authors include Cheng Luo, Hualiang Jiang, Xiangqian Kong, Zhongjie Liang, Sisheng Ouyang, Liang Zhang, Guoliang Xu, Qing Dai, Xingyu Lu and Chuan He. Their work appears in journals such as Blood, PLoS ONE, Leukemia, Journal of Medicinal Chemistry and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.